KHPG(SZ:002773) Zheng Quan Shi Bao Wang·2026-01-05 04:33Group 1 - Kanghong Pharmaceutical's subsidiary Chengdu Hongji Biotechnology Co., Ltd. has received approval from the National Medical Products Administration for clinical trials of KH631 eye injection, aimed at treating diabetic macular edema (DME) [1] Group 2 - Nepean Mining Machine has received approval from the China Securities Regulatory Commission for the registration of a convertible bond issuance to unspecified investors [2] - Tianqi Co., Ltd.'s controlling shareholder Huang Weixing has released 4 million shares from pledge, which represents 0.99% of the company's total share capital [2] - Huang Weixing and his concerted parties have a total of 8.9848 million pledged shares maturing in the next six months, accounting for 2.23% of the total share capital, and 29.59 million shares maturing within a year, representing 7.36% of the total share capital [2]